Biotricity Sale Purchase Of Stock vs Begin Period Cash Flow Analysis
BTCY Stock | USD 1.21 0.02 1.68% |
Biotricity financial indicator trend analysis is way more than just evaluating Biotricity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biotricity is a good investment. Please check the relationship between Biotricity Sale Purchase Of Stock and its Begin Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Sale Purchase Of Stock vs Begin Period Cash Flow
Sale Purchase Of Stock vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biotricity Sale Purchase Of Stock account and Begin Period Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Biotricity's Sale Purchase Of Stock and Begin Period Cash Flow is -0.59. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Biotricity, assuming nothing else is changed. The correlation between historical values of Biotricity's Sale Purchase Of Stock and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Biotricity are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Sale Purchase Of Stock i.e., Biotricity's Sale Purchase Of Stock and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.59 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Sale Purchase Of Stock
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most indicators from Biotricity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 11.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.2 M in 2024.
Biotricity fundamental ratios Correlations
Click cells to compare fundamentals
Biotricity Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biotricity fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.0M | 4.4M | 16.7M | 6.5M | 7.5M | 7.9M | |
Short Long Term Debt Total | 2.3M | 4.7M | 15.4M | 19.5M | 22.5M | 23.6M | |
Other Current Liab | 427.6K | 3.6M | 520.7K | 1.0M | 1.2M | 977.3K | |
Total Current Liabilities | 3.8M | 10.5M | 4.9M | 11.2M | 12.8M | 13.5M | |
Total Stockholder Equity | (3.0M) | (6.8M) | (2.1M) | (19.8M) | (17.9M) | (17.0M) | |
Net Debt | 1.4M | 2.5M | 3.3M | 19.0M | 21.8M | 22.9M | |
Retained Earnings | (46.4M) | (62.8M) | (93.0M) | (112.6M) | (101.3M) | (96.2M) | |
Accounts Payable | 1.1M | 1.0M | 1.2M | 3.4M | 4.0M | 4.1M | |
Cash | 949.8K | 2.2M | 12.1M | 570.5K | 656.0K | 623.2K | |
Cash And Short Term Investments | 949.8K | 2.2M | 12.1M | 570.5K | 656.0K | 623.2K | |
Net Receivables | 623.3K | 1.8M | 2.4M | 1.8M | 2.1M | 2.2M | |
Common Stock Total Equity | 31.9K | 35.4K | 36.4K | 39.0K | 44.9K | 27.8K | |
Common Stock Shares Outstanding | 6.0M | 6.3M | 7.6M | 8.7M | 10.0M | 7.3M | |
Liabilities And Stockholders Equity | 2.0M | 4.4M | 16.7M | 6.5M | 7.5M | 7.9M | |
Non Current Liabilities Total | 1.2M | 780.9K | 14.0M | 15.2M | 17.5M | 18.3M | |
Other Stockholder Equity | 44.2M | 56.6M | 91.6M | 92.8M | 106.7M | 112.1M | |
Total Liab | 5.0M | 11.3M | 18.8M | 26.4M | 30.3M | 31.8M | |
Total Current Assets | 1.7M | 4.3M | 15.3M | 4.7M | 5.4M | 3.2M | |
Accumulated Other Comprehensive Income | (857.3K) | (634.2K) | (768.7K) | (152.8K) | (137.5K) | (144.4K) | |
Short Term Debt | 2.3M | 4.3M | 1.8M | 5.1M | 5.9M | 6.2M | |
Common Stock | 36.4K | 39.0K | 51.3K | 52.5K | 60.4K | 33.8K | |
Net Tangible Assets | (1.8M) | (3.0M) | (6.8M) | (2.1M) | (1.9M) | (2.0M) | |
Non Current Assets Total | 345.6K | 116.5K | 1.4M | 1.8M | 2.1M | 2.2M | |
Short Term Investments | 137.1K | 326.7K | 302.3K | 588.6K | 676.9K | 710.7K | |
Inventory | 85.7K | 272.5K | 842.9K | 2.3M | 2.7M | 2.8M | |
Other Current Assets | 137.1K | 326.7K | 406.3K | 588.6K | 676.9K | 710.7K | |
Short Long Term Debt | 2.1M | 4.3M | 1.5M | 4.8M | 5.5M | 5.8M | |
Net Invested Capital | (932.1K) | (2.2M) | 11.9M | (2.0M) | (2.3M) | (2.2M) | |
Net Working Capital | (2.1M) | (6.2M) | 10.5M | (6.4M) | (5.8M) | (5.5M) | |
Capital Stock | 36.4K | 39.0K | 51.3K | 52.5K | 60.4K | 47.2K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Biotricity Stock analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 1.319 | Quarterly Revenue Growth 0.209 | Return On Assets (0.95) | Return On Equity (41.01) |
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.